Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Anixa, biochemistry, Biology, biopsy, Blocker, career, cigarette, clause, COD, Connecticut, copy, DC, domain, Electrical, encompassing, escrow, ExThera, FY, Garret, GHS, Greenwich, Havemeyer, head, Hetterly, Hologic, IBXXF, immunology, Inivata, John, JUUL, LABSCO, Marlboro, Master, McKesson, Middle, MKA, Munich, ninety, Physiology, Pictor, predecessor, Premium, proxy, Qiagen, Roche, Sahney, Sandy, Schlumpberger, SIEN, Sientra, Tadd, Treasure, Vice, Vidur, VP, Washington, West, withheld, withholding, Woodley
Filing tables
Filing exhibits
NNMX similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Nanomix Corporation (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: April 7, 2023 | By: | /s/ Thomas Schlumpberger |
Thomas Schlumpberger | ||
Chief Executive Officer | ||
(Principal Executive Officer) |